Neurocrine Biosciences shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Neurocrine Biosciences by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $107M | 761k | 140.38 |
| 2025-06-30 | $98M | 779k | 125.69 |
| 2025-03-31 | $92M | 829k | 110.60 |
| 2024-12-31 | $119M | 870k | 136.50 |
| 2024-09-30 | $99M | 858k | 115.22 |
| 2024-06-30 | $129M | 934k | 137.67 |
| 2024-03-31 | $127M | 921k | 137.92 |
| 2023-12-31 | $129M | 979k | 131.76 |
| 2023-09-30 | $173M | 1.5M | 112.50 |
| 2023-06-30 | $150M | 1.6M | 94.30 |
| 2023-03-31 | $167M | 1.7M | 101.22 |
| 2022-12-31 | $201M | 1.7M | 119.44 |
| 2022-09-30 | $186M | 1.7M | 106.60 |
| 2022-06-30 | $166M | 1.7M | 97.48 |
| 2022-03-31 | $160M | 1.7M | 93.75 |
| 2021-12-31 | $160M | 1.9M | 85.64 |
| 2021-09-30 | $0 | 1.9M | 0.00 |
| 2021-06-30 | $196M | 2.0M | 97.32 |
| 2021-03-31 | $188M | 1.9M | 97.25 |
| 2020-12-31 | $112M | 1.2M | 95.85 |
| 2020-09-30 | $107M | 1.1M | 96.16 |
| 2020-06-30 | $118M | 973k | 121.37 |
| 2020-03-31 | $71M | 823k | 86.55 |
| 2019-12-31 | $68M | 629k | 107.49 |
| 2019-09-30 | $84M | 928k | 90.11 |
| 2019-06-30 | $81M | 953k | 84.43 |
| 2019-03-31 | $84M | 955k | 88.10 |
| 2018-12-31 | $69M | 969k | 71.41 |
| 2018-09-30 | $124M | 1.0M | 122.95 |
| 2018-06-30 | $120M | 1.2M | 98.24 |
| 2018-03-31 | $111M | 1.3M | 82.93 |
| 2017-12-31 | $115M | 1.5M | 77.59 |
| 2017-06-30 | $101M | 2.2M | 46.00 |
| 2017-03-31 | $83M | 1.9M | 43.30 |
| 2016-12-31 | $54M | 1.4M | 38.70 |
| 2016-09-30 | $71M | 1.4M | 50.64 |
| 2016-06-30 | $19M | 416k | 45.45 |